Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tagrisso Tablets Clinical Experience Investigation (All Case Investigation)

NCT02756039 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02756039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02756039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tagrisso Tablets Clinical Experience Investigation (All Case Investigation)
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 25, 2016
Completion date
August 31, 2018
Enrollment
3,494 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

all patients treated with the product